These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33888872)

  • 41. Amyloid tracers binding sites in autosomal dominant and sporadic Alzheimer's disease.
    Ni R; Gillberg PG; Bogdanovic N; Viitanen M; Myllykangas L; Nennesmo I; Långström B; Nordberg A
    Alzheimers Dement; 2017 Apr; 13(4):419-430. PubMed ID: 27693181
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Longitudinal association between astrocyte function and glucose metabolism in autosomal dominant Alzheimer's disease.
    Carter SF; Chiotis K; Nordberg A; Rodriguez-Vieitez E
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):348-356. PubMed ID: 30515545
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel reference region model reveals increased microglial and reduced vascular binding of 11C-(R)-PK11195 in patients with Alzheimer's disease.
    Tomasi G; Edison P; Bertoldo A; Roncaroli F; Singh P; Gerhard A; Cobelli C; Brooks DJ; Turkheimer FE
    J Nucl Med; 2008 Aug; 49(8):1249-56. PubMed ID: 18632810
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles.
    Hostetler ED; Walji AM; Zeng Z; Miller P; Bennacef I; Salinas C; Connolly B; Gantert L; Haley H; Holahan M; Purcell M; Riffel K; Lohith TG; Coleman P; Soriano A; Ogawa A; Xu S; Zhang X; Joshi E; Della Rocca J; Hesk D; Schenk DJ; Evelhoch JL
    J Nucl Med; 2016 Oct; 57(10):1599-1606. PubMed ID: 27230925
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In Vivo Detection of Age- and Disease-Related Increases in Neuroinflammation by 18F-GE180 TSPO MicroPET Imaging in Wild-Type and Alzheimer's Transgenic Mice.
    Liu B; Le KX; Park MA; Wang S; Belanger AP; Dubey S; Frost JL; Holton P; Reiser V; Jones PA; Trigg W; Di Carli MF; Lemere CA
    J Neurosci; 2015 Nov; 35(47):15716-30. PubMed ID: 26609163
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of [11C]TAZA for amyloid β plaque imaging in postmortem human Alzheimer's disease brain region and whole body distribution in rodent PET/CT.
    Pan ML; Mukherjee MT; Patel HH; Patel B; Constantinescu CC; Mirbolooki MR; Liang C; Mukherjee J
    Synapse; 2016 Apr; 70(4):163-76. PubMed ID: 26806100
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo imaging of microglial activation by positron emission tomography with [(11)C]PBR28 in the 5XFAD model of Alzheimer's disease.
    Mirzaei N; Tang SP; Ashworth S; Coello C; Plisson C; Passchier J; Selvaraj V; Tyacke RJ; Nutt DJ; Sastre M
    Glia; 2016 Jun; 64(6):993-1006. PubMed ID: 26959396
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vivo visualization of donepezil binding in the brain of patients with Alzheimer's disease.
    Okamura N; Funaki Y; Tashiro M; Kato M; Ishikawa Y; Maruyama M; Ishikawa H; Meguro K; Iwata R; Yanai K
    Br J Clin Pharmacol; 2008 Apr; 65(4):472-9. PubMed ID: 18070217
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autoradiographic localisation of [3H]2-BFI imidazoline I2 binding sites in mouse brain.
    MacInnes N; Handley SL
    Eur J Pharmacol; 2005 Jun; 516(2):139-44. PubMed ID: 15925361
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Imaging Neuroinflammation: Quantification of Astrocytosis in a Multitracer PET Approach.
    Rodriguez-Vieitez E; Nordberg A
    Methods Mol Biol; 2018; 1750():231-251. PubMed ID: 29512077
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Semaphorin 4D is upregulated in neurons of diseased brains and triggers astrocyte reactivity.
    Evans EE; Mishra V; Mallow C; Gersz EM; Balch L; Howell A; Reilly C; Smith ES; Fisher TL; Zauderer M
    J Neuroinflammation; 2022 Aug; 19(1):200. PubMed ID: 35933420
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Brain Imaging of Alzheimer Dementia Patients and Elderly Controls with
    Lohith TG; Bennacef I; Vandenberghe R; Vandenbulcke M; Salinas CA; Declercq R; Reynders T; Telan-Choing NF; Riffel K; Celen S; Serdons K; Bormans G; Tsai K; Walji A; Hostetler ED; Evelhoch JL; Van Laere K; Forman M; Stoch A; Sur C; Struyk A
    J Nucl Med; 2019 Jan; 60(1):107-114. PubMed ID: 29880509
    [No Abstract]   [Full Text] [Related]  

  • 53. Correlations of
    Harada R; Ishiki A; Kai H; Sato N; Furukawa K; Furumoto S; Tago T; Tomita N; Watanuki S; Hiraoka K; Ishikawa Y; Funaki Y; Nakamura T; Yoshikawa T; Iwata R; Tashiro M; Sasano H; Kitamoto T; Yanai K; Arai H; Kudo Y; Okamura N
    J Nucl Med; 2018 Apr; 59(4):671-674. PubMed ID: 28864633
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Validation of an (18)F-labeled biphenylalkyne as a positron emission tomography imaging agent for beta-amyloid plaques.
    Wey SP; Weng CC; Lin KJ; Yao CH; Yen TC; Kung HF; Skovronsky D; Kung MP
    Nucl Med Biol; 2009 May; 36(4):411-7. PubMed ID: 19423009
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Imidazoline ligand BU224 reverses cognitive deficits, reduces microgliosis and enhances synaptic connectivity in a mouse model of Alzheimer's disease.
    Mirzaei N; Mota BC; Birch AM; Davis N; Romero-Molina C; Katsouri L; Palmer EOC; Golbano A; Riggall LJ; Nagy I; Tyacke R; Nutt DJ; Sastre M
    Br J Pharmacol; 2021 Feb; 178(3):654-671. PubMed ID: 33140839
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cortical laminar tau deposits and activated astrocytes in Alzheimer's disease visualised by
    Lemoine L; Saint-Aubert L; Nennesmo I; Gillberg PG; Nordberg A
    Sci Rep; 2017 Apr; 7():45496. PubMed ID: 28374768
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fluselenamyl: A Novel Benzoselenazole Derivative for PET Detection of Amyloid Plaques (Aβ) in Alzheimer's Disease.
    Sundaram GS; Dhavale DD; Prior JL; Yan P; Cirrito J; Rath NP; Laforest R; Cairns NJ; Lee JM; Kotzbauer PT; Sharma V
    Sci Rep; 2016 Nov; 6():35636. PubMed ID: 27805057
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy.
    Passamonti L; Vázquez Rodríguez P; Hong YT; Allinson KS; Williamson D; Borchert RJ; Sami S; Cope TE; Bevan-Jones WR; Jones PS; Arnold R; Surendranathan A; Mak E; Su L; Fryer TD; Aigbirhio FI; O'Brien JT; Rowe JB
    Brain; 2017 Mar; 140(3):781-791. PubMed ID: 28122879
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
    Tosun D; Schuff N; Jagust W; Weiner MW;
    Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.
    Chaney AM; Lopez-Picon FR; Serrière S; Wang R; Bochicchio D; Webb SD; Vandesquille M; Harte MK; Georgiadou C; Lawrence C; Busson J; Vercouillie J; Tauber C; Buron F; Routier S; Reekie T; Snellman A; Kassiou M; Rokka J; Davies KE; Rinne JO; Salih DA; Edwards FA; Orton LD; Williams SR; Chalon S; Boutin H
    Theranostics; 2021; 11(14):6644-6667. PubMed ID: 34093845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.